Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T61230 |
Anticancer agent 74
|
||
Anticancer agent 74 exhibits moderate anticancer activity with lower selectivity and cytotoxicity compared to doxorubicin towards normal cells [1]. |